These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12501745)

  • 1. Influenza vaccine-associated adverse events: results of passive surveillance, Canada 2001-2002.
    Choudhri Y; Walop W
    Can Commun Dis Rep; 2002 Dec; 28(23):189-96. PubMed ID: 12501745
    [No Abstract]   [Full Text] [Related]  

  • 2. NSW Annual Adverse Events Following Immunisation Report, 2009.
    Mahajan D; Campbell-Lloyd S; Roomiani I; Menzies RI
    N S W Public Health Bull; 2010; 21(9-10):224-33. PubMed ID: 21211475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oculo-respiratory syndrome following influenza vaccination: review of post-marketing surveillance through four influenza seasons in Canada.
    Can Commun Dis Rep; 2005 Nov; 31(21):217-25. PubMed ID: 16669126
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons.
    De Serres G; Toth E; Ménard S; Grenier JL; Roussel R; Tremblay M; Landry M; Robert Y; Rochette L; Skowronski DM
    Vaccine; 2005 May; 23(28):3726-32. PubMed ID: 15882534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of influenza in children hospitalized in Canada, 2004-2005, in Immunization Monitoring Program Active (IMPACT) centres.
    Can Commun Dis Rep; 2006 Apr; 32(7):77-86. PubMed ID: 16649286
    [No Abstract]   [Full Text] [Related]  

  • 7. Intranasal influenza vaccine in a working population.
    Sendi P; Locher R; Bucheli B; Battegay M
    Clin Infect Dis; 2004 Apr; 38(7):974-80. PubMed ID: 15034829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?
    Skowronski DM; Strauss B; De Serres G; MacDonald D; Marion SA; Naus M; Patrick DM; Kendall P
    Clin Infect Dis; 2003 Mar; 36(6):705-13. PubMed ID: 12627354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
    Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
    Vellozzi C; Burwen DR; Dobardzic A; Ball R; Walton K; Haber P
    Vaccine; 2009 Mar; 27(15):2114-20. PubMed ID: 19356614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons.
    De Serres G; Skowronski DM; Guay M; Rochette L; Jacobsen K; Fuller T; Duval B
    Arch Intern Med; 2004 Nov; 164(20):2266-72. PubMed ID: 15534165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years.
    Belshe RB; Nichol KL; Black SB; Shinefield H; Cordova J; Walker R; Hessel C; Cho I; Mendelman PM
    Clin Infect Dis; 2004 Oct; 39(7):920-7. PubMed ID: 15472840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring vaccine safety during an influenza pandemic.
    Iskander J; Haber P; Herrera G
    Yale J Biol Med; 2005 Oct; 78(5):265-75. PubMed ID: 17132333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; DeStefano F; Iskander JK; Haber P; Chen RT;
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):505-10. PubMed ID: 15317028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of adverse events reported following use of yellow fever vaccine--Canada, 1987-2000.
    Choudri Y; Walop W
    Can Commun Dis Rep; 2002 Jan; 28(2):9-15. PubMed ID: 11847905
    [No Abstract]   [Full Text] [Related]  

  • 18. Influenza in Canada: 2001-2002 season.
    Macey JF; Tam TW; Li Y; Winchester B; Zabchuk P
    Can Commun Dis Rep; 2003 Mar; 29(6):45-59. PubMed ID: 12666540
    [No Abstract]   [Full Text] [Related]  

  • 19. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.
    Juurlink DN; Stukel TA; Kwong J; Kopp A; McGeer A; Upshur RE; Manuel DG; Moineddin R; Wilson K
    Arch Intern Med; 2006 Nov; 166(20):2217-21. PubMed ID: 17101939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events temporally associated with immunizing agents--1988 report.
    Duclos P; McCarthy R; Koch J; Carter A
    Can Dis Wkly Rep; 1990 Aug; 16(32):157-64. PubMed ID: 2208346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.